Your browser doesn't support javascript.
loading
The Evolution of a Large Biobank at Mass General Brigham.
Boutin, Natalie T; Schecter, Samantha B; Perez, Emma F; Tchamitchian, Natasha S; Cerretani, Xander R; Gainer, Vivian S; Lebo, Matthew S; Mahanta, Lisa M; Karlson, Elizabeth W; Smoller, Jordan W.
Affiliation
  • Boutin NT; Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
  • Schecter SB; Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
  • Perez EF; Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Tchamitchian NS; Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
  • Cerretani XR; Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
  • Gainer VS; Mass General Brigham Research Information Science & Computing, Boston, MA 02115, USA.
  • Lebo MS; Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
  • Mahanta LM; Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Karlson EW; Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
  • Smoller JW; Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
J Pers Med ; 12(8)2022 Aug 17.
Article in En | MEDLINE | ID: mdl-36013271
The Mass General Brigham Biobank (formerly Partners HealthCare Biobank) is a large repository of biospecimens and data linked to extensive electronic health record data and survey data. Its objective is to support and enable translational research focused on genomic, environmental, biomarker and family history associations with disease phenotypes. The Biobank has enrolled more than 135,000 participants, generated genomic data on more than 65,000 of its participants, distributed approximately 153,000 biospecimens, and served close to 450 institutional studies with biospecimens or data. Although the Biobank has been successful, based on some measures of output, this has required substantial institutional investment. In addition, several challenges are ongoing, including: (1) developing a sustainable cost model that doesn't rely as heavily on institutional funding; (2) integrating Biobank operations into clinical workflows; and (3) building a research resource that is diverse and promotes equity in research. Here, we describe the evolution of the Biobank and highlight key lessons learned that may inform other efforts to build biobanking efforts in health system contexts.
Key words

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Pers Med Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Pers Med Year: 2022 Type: Article Affiliation country: United States